Trial Profile

A Phase 2, Randomized, Double-Blind, Multi-center Study Comparing CLP Versus Placebo in Heart Failure Patients With Chronic Kidney Disease

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 19 Feb 2014

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Talinexomer (Primary)
Indications Heart failure; Kidney disorders
Focus Adverse reactions
Sponsors Sorbent Therapeutics

Most Recent Events

10 Sep 2012 Data presented at the 16th Annual Meeting of the Heart Failure Society of America, according to a Sorbent Therapeutics media release
23 May 2012 New source identified and integrated (ClinicalTrials.gov)
22 May 2012 Data presented at the Annual European Society of Cardiology Heart Failure Congress, according to a Sorbent Therapeutics media release

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com